Contact this trialFirst, we need to learn more about you.
Epigenetic Modulator
HBI-2438 for Cancer with KRAS G12C Mutation
Recruiting1 awardPhase 1
Kansas City, Missouri
This trial is testing a new drug to see what dose is safe for people with cancer that has a specific gene mutation. They will also look at how the body processes the drug.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.